Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for the treatment of mania in bipolar disorder
IRCT20090117001556N157Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in bipolar disorder (BD), sponsored by Tehran University of Medical Sciences. Primary endpoint: Mania severity. Started May 2024; status: completed.
02
Drugs
pentoxifylline
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT20090117001556N157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N157.